The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...